Id proteins in development, cell cycle and cancer

Trends in Cell Biology

Volumn 13, Issue 8, 2003, Pages 410-418

  Ruzinova, Marianna B ^a   Benezra, Robert ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; E PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BREAST CANCER; CANCER GRADING; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CORRELATION ANALYSIS; CYTOLOGY; DISEASE MARKER; DNA BINDING; DOWNSTREAM PROCESSING; DRUG SENSITIVITY; ENDOTHELIUM CELL; EWING SARCOMA; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; IMMUNE SYSTEM; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE; THYROID MEDULLARY CARCINOMA; TUMOR CELL; UPREGULATION;

EID: 0042347689     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(03)00147-8     Document Type: Review

References (93)

1. Muller H.J. Further studies on the nature and causes of gene mutations. Jones D.F. Proceedings of the Sixth International Congress of Genetics. 1932;213-255 Brooklyn Botanic Gardens.
2. Massague J., et al. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
3. Nakashima K., et al. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5868-5873.
4. Yanagisawa M., et al. Fate alteration of neuroepithelial cells from neurogenesis to astrocytogenesis by bone morphogenetic proteins. Neurosci. Res. 41:2001;391-396.
5. Hollnagel A., et al. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274:1999;19838-19845.
6. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277:2002;4883-4891.
7. Lopez-Rovira T., et al. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277:2002;3176-3185.
8. Katagiri T., et al. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells. 7:2002;949-960.
9. Kang Y., et al. A self-enabling TGF( response coupled to stress signaling. smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell. 11:2003;915-926.
10. Hacker C., et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:2003;380-386.
11. Sugai M., et al. Essential role of Id2 in negative regulation of IgE class switching. Nat. Immunol. 4:2003;25-30.
12. Goumans M.J., et al. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21:2002;1743-1753.
13. Valdimarsdottir G., et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation. 106:2002;2263-2270.
14. INK4a expression during cellular senescence. Nature. 409:2001;1067-1070.
15. INK4a/pRB pathway. Carcinogenesis. 23:2002;721-725.
16. Lyden D., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 401:1999;670-677.
17. Alani R.M., et al. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7812-7816.
18. Pagliuca A., et al. Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res. 60:2000;1376-1382.
19. Jen Y., et al. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn. 207:1996;235-252.
20. Polsky D., et al. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 61:2001;6008-6011.
21. INK4a contributes to the outcome of cancer therapy. Cell. 109:2002;335-346.
22. Deed R.W., et al. An immediate early human gene encodes an Id-like helix-loop-helix protein and is regulated by protein kinase C activation in diverse cell types. Oncogene. 8:1993;599-607.
23. Alani R.M., et al. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9637-9641.
24. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396:1998;84-88.
25. Nickoloff B.J., et al. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275:2000;27501-27504.
26. Tang J., et al. The helix-loop-helix protein Id-1 delays onset of replicative senescence in human endothelial cells. Lab. Invest. 82:2002;1073-1079.
27. Norton J.D., Atherton G.T. Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol. 18:1998;2371-2381.
28. Romanov S.R., et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 409:2001;633-637.
29. Lasorella A., et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598.
30. Wu L., et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 421:2003;942-947.
31. Sage J., et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050.
32. Prabhu S., et al. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell. Biol. 17:1997;5888-5896.
33. Hara E., et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269:1994;2139-2145.
34. Christy B.A., et al. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1815-1819.
35. Barone M.V., et al. Id proteins control growth induction in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 91:1994;4985-4988.
36. Tournay O., Benezra R. Transcription of the dominant negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate early response gene Egr-1. Mol. Cell. Biol. 16:1996;2418-2430.
37. Ling M.T., et al. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene. 21:2002;8498-8505.
38. Deed R.W., et al. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation. Mol. Cell. Biol. 17:1997;6815-6821.
39. Hara E., et al. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 16:1997;332-342.
40. Lasorella A., et al. Id proteins at the cross-road of development and cancer. Oncogene. 20:2001;8326-8333.
41. Hasskarl J., Munger K. Id proteins - tumor markers or oncogenes? Cancer Biol. Ther. 1:2002;91-96.
42. Vandeputte D.A., et al. Expression and distribution of Id helix-loop-helix proteins in human astrocytic tumors. Glia. 38:2002;329-338.
43. Ouyang X.S., et al. Over expression of ID-1 in prostate cancer. J. Urol. 167:2002;2598-2602.
44. Schindl M., et al. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 61:2001;5703-5706.
45. Schoppmann S.F., et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer. 104:2003;677-682.
46. Uehara N., et al. Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res. 5:2003;R25-R29.
47. Vandesompele J., et al. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene. 22:2003;456-460.
48. Wang Q., et al. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Cancer Res. 63:2003;1631-1635.
49. Wilson J.W., et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61:2001;8803-8810.
50. Fukuma M., et al. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/Ets protein in Ewing sarcoma. Oncogene. 22:2003;1-9.
51. Nishimori H., et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene. 21:2002;8302-8309.
52. Desprez P.Y., et al. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 15:1995;3398-3404.
53. Desprez P.Y., et al. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18:1998;4577-4588.
54. Wice B.M., Gordon J.I. Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem. 273:1998;25310-25319.
55. Morrow M.A., et al. Overexpression of the helix-loop-helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36:1999;491-503.
56. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:2001;1194-1201.
57. Sakurai D., et al. Expression of ID family genes in the synovia from patients with rheumatoid arthritis. Biochem. Biophys. Res. Commun. 284:2001;436-442.
58. Volpert O.V., et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2:2002;473-483.
59. Ledent V., et al. Phylogenetic analysis of the human basic helix-loop-helix proteins. Genome Biol. 3:2002;. RESEARCH0030.
60. Mathew S., et al. Chromosomal assignment of human ID1 and ID2 genes. Genomics. 30:1995;385-387.
61. Deed R.W., et al. Structural organisation and chromosomal mapping of the human Id-3 gene. Gene. 151:1994;309-314.
62. Springhorn J.P., et al. Posttranscriptional regulation of Id1 activity in cardiac muscle. Alternative splicing of novel Id1 transcript permits homodimerization. J. Biol. Chem. 269:1994;5132-5136.
63. Chaudhary J., et al. Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology. 142:2001;1727-1736.
64. Deed R.W., et al. Attenuated function of a variant form of the helix-loop-helix protein, Id-3, generated by an alternative splicing mechanism. FEBS Lett. 393:1996;113-116.
65. Deed R.W., et al. Nucleotide sequence of the cDNA encoding human helix-loop-helix Id-1 protein: identification of functionally conserved residues common to Id proteins. Biochim. Biophys. Acta. 1219:1994;160-162.
66. Pesce S., Benezra R. The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Mol. Cell. Biol. 13:1993;7874-7880.
67. Moldes M., et al. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem. J. 344:1999;873-880.
68. Shoji W., et al. MIDA1, a protein associated with Id, regulates cell growth. J. Biol. Chem. 270:1995;24818-24825.
69. Roberts E.C., et al. Id helix-loop-helix proteins antagonize Pax transcription factor activity by inhibiting DNA binding. Mol. Cell. Biol. 21:2001;524-533.
70. Iavarone A., et al. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8:1994;1270-1284.
71. Lasorella A., et al. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. Biol. 16:1996;2570-2578.
72. Yates P.R., et al. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J. 18:1999;968-976.
73. Deed R.W., et al. Nuclear localization and regulation of Id protein through an E protein-mediated chaperone mechanism. J. Biol. Chem. 271:1996;23603-23606.
74. Atherton G.T., et al. Regulation of cell differentiation in C2C12 myoblasts by the Id3 helix-loop-helix protein. Cell Growth Differ. 7:1996;1059-1066.
75. Kondo T., Raff M. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J. 19:2000;1998-2007.
76. Yokota Y., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706.
77. Kee B.L., et al. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β Nat. Immunol. 2:2001;242-247.
78. Cammenga J., et al. Induction of C/EBPα activity alters gene expression and differentiation of human CD34+ cells. Blood. 101:2003;2206-2214.
79. Lister J., et al. Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Id1. J. Biol. Chem. 270:1995;17939-17946.
80. Lister J.A., Baron M.H. Induction of basic helix-loop-helix protein-containing complexes during erythroid differentiation. Gene Expr. 7:1998;25-38.
81. Porcher C., et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47-57.
82. Deed R.W., et al. Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J. Biol. Chem. 273:1998;8278-8286.
83. Cai L., et al. Misexpression of basic helix-loop-helix genes in the murine cerebral cortex affects cell fate choices and neuronal survival. Development. 127:2000;3021-3030.
84. Wang S., et al. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron. 29:2001;603-614.
85. Martinsen B.J., Bronner-Fraser M. Neural crest specification regulated by the helix-loop-helix repressor Id2. Science. 281:1998;988-991.
86. Jen Y., et al. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 208:1997;92-106.
87. Duncan M., et al. The gene for the helix-loop-helix protein. Id, is specifically expressed in neural precursors. Dev. Biol. 154:1992;1-10.
88. Yan W., et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327.
89. Pan L., et al. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19:1999;5969-5980.
90. Rivera R.R., et al. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity. 12:2000;17-26.
91. Kusunoki T., et al. TH2 dominance and defective development of a CD8? dendritic cell subset in Id2-deficient mice. J. Allergy Clin. Immunol. 111:2003;136-142.
92. Mori S., et al. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J. 19:2000;5772-5781.
93. Yokota Y. Id and development. Oncogene. 20:2001;8290-8298.